These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

2810 related items for PubMed ID: 18071951

  • 1. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA, Hu P, Epstein AL.
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [Abstract] [Full Text] [Related]

  • 2. B7.1/NHS76: a new costimulator fusion protein for the immunotherapy of solid tumors.
    Liu A, Hu P, Khawli LA, Epstein AL.
    J Immunother; 2006; 29(4):425-35. PubMed ID: 16799338
    [Abstract] [Full Text] [Related]

  • 3. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion.
    Li J, Hu P, Khawli LA, Epstein AL.
    Cancer Res; 2003 Dec 01; 63(23):8384-92. PubMed ID: 14679000
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci.
    Kanwar JR, Kanwar RK, Pandey S, Ching LM, Krissansen GW.
    Cancer Res; 2001 Mar 01; 61(5):1948-56. PubMed ID: 11280751
    [Abstract] [Full Text] [Related]

  • 8. Combination B7-Fc fusion protein treatment and Treg cell depletion therapy.
    Liu A, Hu P, Khawli LA, Epstein AL.
    Clin Cancer Res; 2005 Dec 01; 11(23):8492-502. PubMed ID: 16322313
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Prospects and limitations of recombinant poxviruses for prostate cancer immunotherapy.
    Hwang C, Sanda MG.
    Curr Opin Mol Ther; 1999 Aug 01; 1(4):471-9. PubMed ID: 11713762
    [Abstract] [Full Text] [Related]

  • 11. In situ expression of soluble B7-1 in the context of oncolytic herpes simplex virus induces potent antitumor immunity.
    Todo T, Martuza RL, Dallman MJ, Rabkin SD.
    Cancer Res; 2001 Jan 01; 61(1):153-61. PubMed ID: 11196154
    [Abstract] [Full Text] [Related]

  • 12. Antitumor vaccination: where we stand.
    Bocchia M, Bronte V, Colombo MP, De Vincentiis A, Di Nicola M, Forni G, Lanata L, Lemoli RM, Massaia M, Rondelli D, Zanon P, Tura S.
    Haematologica; 2000 Nov 01; 85(11):1172-206. PubMed ID: 11074658
    [Abstract] [Full Text] [Related]

  • 13. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C, Gafner V, Villani ME, Borsi L, Berndt A, Kosmehl H, Zardi L, Neri D.
    Cancer Res; 2003 Jun 15; 63(12):3202-10. PubMed ID: 12810649
    [Abstract] [Full Text] [Related]

  • 14. Pretreatment with a monoclonal antibody/interleukin-2 fusion protein directed against DNA enhances the delivery of therapeutic molecules to solid tumors.
    Hornick JL, Khawli LA, Hu P, Sharifi J, Khanna C, Epstein AL.
    Clin Cancer Res; 1999 Jan 15; 5(1):51-60. PubMed ID: 9918202
    [Abstract] [Full Text] [Related]

  • 15. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies.
    Bodey B, Siegel SE, Kaiser HE.
    Anticancer Res; 1996 Jan 15; 16(2):661-74. PubMed ID: 8687112
    [Abstract] [Full Text] [Related]

  • 16. Molecular immunological approaches to biotherapy of human cancers--a review, hypothesis and implications.
    Becker Y.
    Anticancer Res; 2006 Jan 15; 26(2A):1113-34. PubMed ID: 16619514
    [Abstract] [Full Text] [Related]

  • 17. Targeting costimulatory pathways for tumor immunotherapy.
    Ward RC, Kaufman HL.
    Int Rev Immunol; 2007 Jan 15; 26(3-4):161-96. PubMed ID: 17558743
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 141.